Wednesday, September 26, 2012

Geron up, AAPL down

AAPL down, I added 5 big shares at $667 and bought a Feb 2012 $690 Call for $4,000. Will by a few more shares if the share price goes down under $660.................... ...................................................................................... Geron up a little, waiting on news..................................................... ....................................................................................... ACTC flat need some news,.............................................................. .............................................................................................................................................................................. Good luck in this rigged casino,

Tuesday, September 25, 2012

Geron , ACTC, AAPL all down

Geron closed down 5 cents at $1.70 on 1.2 million shares. The three month avg. is 1.6 million shares. We still around here without any good news........................................................................................................................................................................... ACTC down under 8 cents at 0.0763 on 4.6 million shares. The 3 month avg. is 6.1 million shares. Need goods news or we go lower......................................................................................................................................................................... AAPL $673.53 down $17,25 on 18.5 million shares. The three month avg. volume is 14.4 million shares. Going to buy a few shares Thurs. We could see $650.......................................................................................................................................................................... Good luck in this rigged casino,

Monday, September 24, 2012

AAPL down

AAPL down to close at $690.79 on 22.7 million shares. The three month avg. volume is 14.1 million shares. I think I may buy a few shares or buy a Jan 2014 $800 call, but that's a $5,600 bet................................................................... ACTC down a little under 8 cents at 0.0785 on 6.6 million shares. The three month avg. volume is 6.1 million shares. May add a few thousand shares. Geron closed at $1.75 on 1.5 million shares. Thinking we stay here for a few weeks until there is news, hopefully good............................................... Good luck in this rigged casino,

Friday, September 21, 2012

Geron filed Form 3 with SEC

Geron was up and closed at $1.765 on 2 million shares. The three month avg. volume is 1.6 million shares. Form 3 is for Executive Vice President Andrew J. Grethlein who will be getting 600,000 shares of Geron. Here's his deal: 75,000 shares on March 17, 2013, the rest of the 525,000 shares in a series of 42 equal monthly installments commencing March 17, 2013. That's a good deal and you know he's going to be working hard to get the stock price up by March 17, 2013 and every month after that........................ ACTC closed down a little at 0.08 on 15.6 million shares. The three month avg. volume is 5.9 million shares. Great volume but not great price action. Need more great news .. ........................................................................................ AAPL up over $700 to close at $700.09 on 19.4 million shares. The three month avg. volume is 14 million shares. .......................................................... Good luck in this rigged casino,

Thursday, September 20, 2012

ACTC up on good news

The last blog, ACTC got $35 million and that will keep them in business for 2 more years. ACTC closed up a little at 0.0840 on 38.5 million shares. The three month avg. volume is 5.5 million shares. Great volume not much of a price move up. Still need more good news on the Phase1/2 trials ............................................................................................................................................................................................................................................................. Geron was up one cent at $1.71 on 3.8 million shares. The three month avg. is 1.5 million shares. I think we stay around $1.50-$1.80 until we get some good news..................................................................................... AAPL closed down little at $698.70 on 12 million shares. The three month avg. volume is 14 million............................................................................. ........................................................................................ Good luck in this rigged casino,

Good News for ACTC

Advanced Cell Technology Secures New $35 Million Funding Commitment from Lincoln Park Capital ................................................................................. Sep 20, 2012 08:30:01 (ET).............................................................. MARLBOROUGH, Mass., Sep 20, 2012 (BUSINESS WIRE) -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it has entered into a $35 million common stock purchase agreement with Lincoln Park Capital Fund, LLC ("Lincoln Park Capital") a Chicago-based institutional investor. Upon executing the agreement, Lincoln Park Capital made an initial purchase of $800,000 in common stock from the Company at a purchase price of $0.08 per share. The Company has agreed to file a registration statement with the U.S. Securities & Exchange Commission ("SEC") covering the shares that may be issued to Lincoln Park Capital under the terms of the common stock purchase agreement. After the SEC has declared the registration statement related to the transaction effective, the Company has the right at its sole discretion over a period of three years to sell up to an additional $34.2 million of its common stock to Lincoln Park Capital under the terms set forth in the agreement. Proceeds from this transaction will be used to fund the company's clinical activities, including its three ongoing Phase I/II clinical trials for forms of macular degeneration, for development of its other clinical activities, and for general corporate purposes............................................................................... "We are most pleased about this financing agreement, as it has a number of notable benefits for the company," commented Gary Rabin, chairman and CEO of ACT. "Lincoln Park Capital is an excellent partner for us with a great track record and a long-term commitment to the life sciences field. This transaction offers the Company a very cost efficient and readily available form of financing. The $35 million available under the agreement equates to more than two years of funding for the Company, even assuming no other sources of capital. It was a priority for us to complete a new financing by year-end, as we never again want to be in a position to have to go looking for capital from a position of distress or weakness. This agreement strengthens our balance sheet allowing us to focus on advancing our clinical programs, pursuing strategic partnerships, and other long-term objectives.".......................................... Under the terms of the agreement, there are no upper limits to the price that Lincoln Park Capital may pay to purchase the Company's common stock and this transaction in no way impedes or changes the Company's goal of completing a reverse split and national listing. The Company plans to continue pursuing its stated corporate milestones of achieving a national listing and pursuing the optimal corporate partnerships for its programs. The Lincoln Park financing commitment simply strengthens the Company's balance sheet and makes available an additional source of funding. In consideration for entering into the $35 million agreement, the Company has issued additional shares to Lincoln Park Capital as a commitment fee. Under the terms of the agreement, Lincoln Park Capital has covenanted not to cause or engage in any manner whatsoever, any direct or indirect short selling or hedging of the Company's shares of common stock. Josh Scheinfeld, Managing Member of Lincoln Park Capital, said, "We are very pleased to be entering into this agreement with Advanced Cell Technology. We at Lincoln Park have been following the progression of the Company over the past several years and are excited to be making this investment. We are impressed by the Company's technology and the clinical data that has been published to date." Additional details regarding the financing are included in a Current Report on Form 8-K filed on September 19, 2012 by the Company with the Securities and Exchange Commission. About Advanced Cell Technology, Inc. Advanced Cell Technology, Inc., is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit www.advancedcell.com .

Wednesday, September 19, 2012

Geron closed up 16 cents

Well, still no news on why the run up on good volume. Any move up is good. Geron closed at $1.67 on 3.6 million shares. The three month avg. is 1.5 million shares. ............ ACTC was down a little at 0.08 cents on 3.7 million shares. The three month avg. volume is 5.5 million shares. Need some good news.............................................. AAPL up just a little at $702.10 on 11.6 million shares. Volume going down could mean price as peaked for now................................................................ Good luck in this rigged casino,